Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors

Osteoclasts were isolated from membranous bone from four children without metabolic bone disease who were undergoing craniotomy for either tumor or trauma. Both freshly isolated osteoclasts and those cultured for 4–7 days exhibited the following characteristics: production of tartrate‐resistant acid phosphatase (9.5–14.8 units), contraction in response to application of 100 mg/ml of human calcitonin, and formation of resorption lacunae on devitalized bone wafers. Nuclear estrogen and progesterone receptors were demonstrated by immunohistochemical techniques and quantitated in two of the patients by radioimmunoassay (estrogen receptor RIA, 23.6 and 23.8 cpm/μg protein; progesterone receptor RIA, 36.7 and 74.2 cpm/μg protein). The demonstration of sex steroid hormone receptors in the nucleus of osteoclasts derived from children with normal membranous bone has estabished a potential mechanism whereby direct modulation of bone resorption by the sex steroid estrogen and progesterone may occur.

[1]  C. Langman,et al.  Sex steroid hormone receptors in normal and dysplastic bone disorders in children , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  R. Schmidt,et al.  Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Albright syndrome). , 1988, The New England journal of medicine.

[3]  Kenneth G. Mann,et al.  Evidence of estrogen receptors in normal human osteoblast-like cells , 1988 .

[4]  B. Komm,et al.  Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. , 1988, Science.

[5]  C. Christiansen,et al.  Total and local bone mineral during estrogen treatment: a placebo controlled trial. , 1986, Bone and mineral.

[6]  J. Shine,et al.  Sequence and expression of human estrogen receptor complementary DNA. , 1986, Science.

[7]  C. Christiansen,et al.  UNCOUPLING OF BONE FORMATION AND RESORPTION BY COMBINED OESTROGEN AND PROGESTAGEN THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS , 1985, The Lancet.

[8]  M. Edgerton,et al.  The surgical treatment of fibrous dysplasia. With emphasis on recent contributions from cranio-maxillo-facial surgery. , 1985, Annals of surgery.

[9]  R. Francis,et al.  The Effect of Estrogen Dose on Postmenopausal Bone Loss , 1983 .

[10]  C. Christiansen,et al.  TREATMENT OF POST MENOPAUSAL OSTEOPOROSIS. A CONTROLLED THERAPEUTIC TRIAL COMPARING OESTROGEN/GESTAGEN, 1,25‐DIHYDROXY‐VITAMIN D3 AND CALCIUM , 1982, Clinical endocrinology.

[11]  K. Matsumoto,et al.  Steroid receptors in osteoblasts. , 1980, Clinical orthopaedics and related research.

[12]  C. Christiansen,et al.  Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females , 1971, European journal of clinical investigation.

[13]  R. Cruess,et al.  The effect of long term estrogen administration on bone metabolism in the female rat. , 1979, Endocrinology.

[14]  D. Feldman,et al.  Distinction between alpha-fetoprotein and intracellular estrogen receptors: evidence against the presence of estradiol receptors in rat bone. , 1978, Endocrinology.

[15]  A. Horsman,et al.  Prospective trial of oestrogen and calcium in postmenopausal women. , 1977, British medical journal.

[16]  B. Busetta,et al.  Some hypotheses about interactions between estrogen and androgen and their possible receptors. , 1977, Journal of steroid biochemistry.

[17]  L. Raisz,et al.  Failure of estrogens and androgens to inhibit bone resorption in tissue culture. , 1976, Endocrinology.

[18]  R. Cruess,et al.  Estrogen Receptors in Bone An Evaluation of the Uptake of Estrogen into Bone Cells 1 , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[19]  J. Gorski,et al.  A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[20]  F. Albright,et al.  POSTMENOPAUSAL OSTEOPOROSIS: ITS CLINICAL FEATURES , 1941 .

[21]  P. Smith,et al.  Syndrome Characterized by Osteitis Fibrosa Disseminata, Areas of Pigmentation and Endocrine Dysfunction, with Precocious Puberty in Females , 1937 .